DLENX vs. MEDIX

Last updated Jun 3, 2026

DLENX (DoubleLine Emerging Markets Fixed Income Fund Class N) and MEDIX (MFS Emerging Markets Debt Fund) are both Emerging Markets Bonds funds. Over the past 10 years, DLENX returned 3.61%/yr vs 3.73%/yr for MEDIX. A 0.70 correlation means they provide meaningful diversification when combined. DLENX charges 1.18%/yr vs 0.81%/yr for MEDIX.

Performance

DLENX vs. MEDIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in DoubleLine Emerging Markets Fixed Income Fund Class N (DLENX) and MFS Emerging Markets Debt Fund (MEDIX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, DLENX achieves a 1.16% return, which is significantly lower than MEDIX's 2.46% return. Both investments have delivered pretty close results over the past 10 years, with DLENX having a 3.61% annualized return and MEDIX not far ahead at 3.73%.

DLENX

• 1D: 0.11%
• 1M: 0.12%
• YTD: 1.16%
• 6M: 1.61%
• 1Y: 6.35%
• 3Y*: 8.01%
• 5Y*: 1.86%
• 10Y*: 3.61%

MEDIX

• 1D: 0.16%
• 1M: 1.09%
• YTD: 2.46%
• 6M: 3.09%
• 1Y: 12.40%
• 3Y*: 9.48%
• 5Y*: 2.13%
• 10Y*: 3.73%

*Multi-year figures are annualized to reflect compound growth (CAGR)

DLENX vs. MEDIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
DLENX DoubleLine Emerging Markets Fixed Income Fund Class N	1.16%	8.11%	7.92%	9.36%	-15.50%	1.71%	4.66%	11.71%	-3.54%	8.31%
MEDIX MFS Emerging Markets Debt Fund	2.46%	12.48%	5.92%	9.42%	-15.97%	-2.40%	8.01%	14.12%	-4.99%	9.64%

Correlation

The correlation between DLENX and MEDIX is 0.65, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.65
Correlation (3Y) Calculated over the trailing 3-year period	0.76
Correlation (5Y) Calculated over the trailing 5-year period	0.79
Correlation (10Y) Calculated over the trailing 10-year period	0.72
Correlation (All Time) Calculated using the full available price history since Apr 7, 2010	0.70

The correlation between DLENX and MEDIX shifts across timeframes, from 0.65 (1 year) to 0.79 (5 years), reflecting how their relationship changes across market environments.

Return for Risk

DLENX vs. MEDIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DLENX

DLENX Risk / Return Rank: 86
DLENX Sharpe Ratio Rank: 94
DLENX Sortino Ratio Rank: 94
DLENX Omega Ratio Rank: 94
DLENX Calmar Ratio Rank: 76
DLENX Martin Ratio Rank: 71

MEDIX

MEDIX Risk / Return Rank: 84
MEDIX Sharpe Ratio Rank: 94
MEDIX Sortino Ratio Rank: 96
MEDIX Omega Ratio Rank: 93
MEDIX Calmar Ratio Rank: 65
MEDIX Martin Ratio Rank: 70

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DLENX vs. MEDIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for DoubleLine Emerging Markets Fixed Income Fund Class N (DLENX) and MFS Emerging Markets Debt Fund (MEDIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DLENX	MEDIX	Difference
Sharpe ratio Return per unit of total volatility	3.26	3.25	+0.01
Sortino ratio Return per unit of downside risk	4.86	5.40	-0.54
Omega ratio Gain probability vs. loss probability	1.76	1.70	+0.07
Calmar ratio Return relative to maximum drawdown	3.45	3.09	+0.36
Martin ratio Return relative to average drawdown	13.77	13.52	+0.25
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DLENX vs. MEDIX - Sharpe Ratio Comparison

The current DLENX Sharpe Ratio is 3.26, which is comparable to the MEDIX Sharpe Ratio of 3.25. The chart below compares the historical Sharpe Ratios of DLENX and MEDIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	DLENX	MEDIX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.26	3.25	+0.01
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.41	0.36	+0.05
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.78	0.64	+0.14
Sharpe Ratio (All Time) Calculated using the full available price history	0.95	0.98	-0.03

Drawdowns

DLENX vs. MEDIX - Drawdown Comparison

The maximum DLENX drawdown since its inception was -25.64%, smaller than the maximum MEDIX drawdown of -35.31%. Use the drawdown chart below to compare losses from any high point for DLENX and MEDIX.

Drawdown Indicators

	DLENX	MEDIX	Difference
Max Drawdown Largest peak-to-trough decline	-25.64%	-35.31%	+9.67%
Max Drawdown (1Y) Largest decline over 1 year	-1.83%	-4.12%	+2.29%
Max Drawdown (3Y) Largest decline over 3 years	-4.58%	-7.48%	+2.90%
Max Drawdown (5Y) Largest decline over 5 years	-25.64%	-27.40%	+1.76%
Max Drawdown (10Y) Largest decline over 10 years	-25.64%	-27.40%	+1.76%
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	-3.61%	-4.44%	+0.83%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.46%	0.94%	-0.48%

Volatility

DLENX vs. MEDIX - Volatility Comparison

The current volatility for DoubleLine Emerging Markets Fixed Income Fund Class N (DLENX) is 0.68%, while MFS Emerging Markets Debt Fund (MEDIX) has a volatility of 1.39%. This indicates that DLENX experiences smaller price fluctuations and is considered to be less risky than MEDIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DLENX	MEDIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.68%	1.39%	-0.71%
Volatility (6M) Calculated over the trailing 6-month period	1.43%	3.22%	-1.79%
Volatility (1Y) Calculated over the trailing 1-year period	1.93%	3.92%	-1.99%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	4.55%	5.89%	-1.34%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	4.66%	5.87%	-1.21%

DLENX vs. MEDIX - Expense Ratio Comparison

DLENX has a 1.18% expense ratio, which is higher than MEDIX's 0.81% expense ratio.

Dividends

DLENX vs. MEDIX - Dividend Comparison

DLENX's dividend yield for the trailing twelve months is around 5.32%, more than MEDIX's 5.04% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
DLENX DoubleLine Emerging Markets Fixed Income Fund Class N	5.32%	5.33%	5.71%	5.29%	4.49%	3.74%	4.11%	4.49%	3.57%	4.07%	4.29%	4.94%
MEDIX MFS Emerging Markets Debt Fund	5.04%	5.22%	5.68%	4.90%	5.51%	4.33%	4.07%	4.59%	4.87%	4.46%	4.86%	5.25%

Frequently Asked Questions

Can I hold both DLENX and MEDIX in my portfolio?

DLENX and MEDIX have a correlation of 0.65, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, DLENX or MEDIX?

MEDIX has higher volatility (1.39%) compared to DLENX (0.68%). In terms of maximum drawdown, DLENX dropped -25.64% vs MEDIX's -35.31%.

Which has better risk-adjusted returns?

DLENX currently has the higher Sharpe Ratio (3.26 vs 3.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.